4610 NEW ZEALAND GAZETTE, No. 163 27 OCTOBER 2011

Product:
Tacrolimus Sandoz
Active Ingredient:
Tacrolimus monohydrate 0.511mg equivalent to Tacrolimus 0.5mg
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Sandoz Private Limited, Navi Mumbai, India

Product:
Tacrolimus Sandoz
Active Ingredient:
Tacrolimus monohydrate 1.022mg equivalent to Tacrolimus 1mg
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Sandoz Private Limited, Navi Mumbai, India

Product:
Tacrolimus Sandoz
Active Ingredient:
Tacrolimus monohydrate 5.1mg equivalent to Tacrolimus 5mg
Dosage Form:
Capsule
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Sandoz Private Limited, Navi Mumbai, India

Dated this 19th day of October 2011.

Dr DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go7358

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Stelara
Active Ingredient:
Ustekinumab 45mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Product:
Stelara
Active Ingredient:
Ustekinumab 90mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Dated this 19th day of October 2011.

Dr DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go7359

Misuse of Drugs Act 1975

Place at Which Controlled Drugs May be Prescribed, Administered, or Supplied for the Purpose of Treating Drug Dependence

Pursuant to section 24(7)(b)(ii) of the Misuse of Drugs Act 1975, I, Susanna Every-Palmer, acting under delegated authority from the Minister of Health, revoke the notice published in the New Zealand Gazette, 13 January 2005, No. 1, page 33, effective from 1 November 2011, and specify that

the clinic at 20 Victoria Street, Masterton, operated by CareNZ
is a place at which controlled drugs may be prescribed, administered or supplied for the purposes of that section.

Dated at Wellington this 25th day of October 2011.

DR SUSANNA EVERY-PALMER, Acting Director of Mental Health.

go7480

Medical Practitioner Who May Prescribe, Administer, or Supply Controlled Drugs for the Purpose of Treating Drug Dependence

Pursuant to section 24(7)(a) of the Misuse of Drugs Act 1975, I, Susanna Every-Palmer, acting under delegated authority from the Minister of Health, specify that Dr Peter Neil Cowley (Medical Council Registration No. 10056) is

a medical practitioner who may prescribe, administer, or supply controlled drugs for the purposes of that section,
subject to the following conditions:

1. The prescription, administration, or supply of controlled drugs for the treatment of dependence is limited to patients of the clinic at 20 Victoria Street, Masterton, operated by CareNZ.

2. The prescription, administration, or supply of controlled drugs for the treatment of dependence is limited to patients dependent on an opioid or opioids.

3. Dr Peter Neil Cowley’s power to authorise other medical practitioners is limited to section 24(2)(b) of the Misuse of Drugs Act 1975, and section